Levin Papantonio
Since its founding in 1955, the law firm of Levin, Papantonio, Thomas, Mitchell, Rafferty & Proctor, P.A. has built a reputation as one of the most successful litigation firms in the United States.
Levin Papantonio (levinlaw) uses Bloggers to connect with peer Bloggers. Join the largest Bloggers Community to follow Levin Papantonio (levinlaw), and build your audience now!
What would you like to say?
Profile Comments
Levin Papantonio ∙ 5 days ago
Actos - Another Blow for Injustice http://www.levinlaw.com/news/actos-another-blow-injustice Earlier this year, the first of 3000 injury cases against Japanese pharmaceutical company Takeda was heard in a Los Angeles court. The allegation: their flagship product, Actos, had caused plaintiff Jack Cooper to develop bladder cancer. Although Mr. Cooper had been a cigarette smoker earlier in life (he managed to quit several years ago) – but there is arguably much more powerful medical evidence demonstrating the connection between the long-term use (six months or more) of Actos and the increased risk of bladder cancer – not to mention heart problems and blindness. (For a simplified explanation of how Actos increases the risk of cancer, go here.)
Levin Papantonio ∙ 1 week 2 days ago
Fresenius Profits Down While Army of Plaintiffs Grow http://www.levinlaw.com/news/fresenius-profits-down-while-army-plaintiffs-grow At the end of March 2013, the U.S. Judicial Panel on Multidistrict Litigation (USJPML) consolidated all pending cases against Granuflo manufacturer Fresenius before the U.S. Federal Court for the District of Massachusetts. This accomplishes two things: it eliminates all duplication of efforts when it comes to the discovery process, and it moves the trial to a venue near Fresenius' U.S. headquarters – making it easier to obtain documents and other evidence that the company knew of the dangers regarding the use of its dialysis product and deliberately withheld this information from doctors and patients. (In fact, Fresenius did share this information – but only with personnel employed at its own private dialysis centers.)
Levin Papantonio ∙ 2 weeks ago
Pradaxa and Boehringer-Ingelheim: Worse Than You Thought? http://www.levinlaw.com/news/pradaxa-and-boehringer-ingelheim-worse-you-thought It's already widely-known that Boehringer-Ingelheim's anti-coagulant drug, Pradaxa, carries a high risk of patients bleeding to death – and, to add insult to injury, costs that are fifteen times those of warfarin (Pradaxa and its new competitor, Xarelto, run $3,000 a year compared to $200 for warfarin). Doctors nonetheless like Pradaxa (dabigatran) because it's relatively trouble-free; there are few interactions with other drugs and the dosage requires far less adjustments over time than warfarin – meaning less in the way of costly patient monitoring.
Levin Papantonio ∙ 2 weeks 6 days ago
Yamaha Embarrassed By Their Disgusting Conduct http://www.ringoffireradio.com/2013/05/02/yamaha-embarrassed-by-their-disgusting-conduct/ Yesterday, Ring of Fire posted a story about a $3.3 million verdict against Yamaha for their gross negligence with their Rhino ATV (model 660 UTV.) The verdict was delivered after attorneys were able to show that during every step of the way – from design, to manufacturing, to marketing – the company put their own desire for profits over the safety of consumers.
Levin Papantonio ∙ 3 weeks ago
Yamaha To Pay $3.3 Million Verdict for Wanton Conduct http://www.levinlaw.com/news/yamaha-pay-33-million-verdict-wanton-conduct A jury in Montgomery, Alabama returned a $3.3 million verdict against Yamaha for its wanton conduct in the design, marketing, manufacture and sale of the Yamaha Rhino Model 660 UTV vehicle. A finding of wantonness means that Yamaha acted or failed to act with a conscious and reckless disregard for the safety of its consumers, knowing that grievous injury was likely to result.
Levin Papantonio ∙ 3 weeks ago
Takeda Pays – But Again, Not Much http://www.levinlaw.com/news/takeda-pays-again-not-much Late last month, a Los Angeles jury decided that Takeda executives were in fact aware of the cancer risk from its flagship product, Actos – and ordered the Japanese pharmaceutical giant to pay $6.5 million to plaintiff Jack Cooper and his wife. Cooper's lawyers presented the court with evidence demonstrating that Takeda executives were aware of the risks associated with Actos as far back as 2004 – yet spent the next seven years hiding this information from regulators. Ironically, this is essentially what whistleblower Helen Ge, a former Takeda medical reviewer, told to a judge several months ago when she filed a qui tam case. The judge threw her case out because her allegations had been insufficiently specific.
Levin Papantonio ∙ 3 weeks 6 days ago
Depuy - He Said, They Said http://www.levinlaw.com/news/depuy-he-said-they-said "DePuy Orthopaedics Hips. Real Life Tested" Those words still appear on a website maintained by the company (play the videos at the bottom or click on “read transcript”). Of course, these are about the newer Pinnacle hip device, not the ASR that so far has cost the company $8.3 million in a single lawsuit – with approximately 10,000 more cases lined up right behind it.
Levin Papantonio ∙ 4 weeks 1 day ago
Pelvic Meshes - “This is Industry-Driven Technology” http://www.levinlaw.com/news/pelvic-meshes-industry-driven-technology Those are the words of one Dr. David Grimes, who in July 2011, speaking to an NBC news reporter about the problems with pelvic meshes, added that “...we have a long history of accepting things without critical appraisal.”
Levin Papantonio ∙ 4 weeks 2 days ago
Hardies Group, LLC – Responsive Web Design For Longmont Architectural Design Company http://bouldermediadesign.com/portfolio/web-design-portfolio/longmont-architectural-design/ Hardies Group, LLC is a Responsive Web Design for A Longmont Architectural Design Company created by Boulder Media Design Responsive Web Design For Longmont Architectural Design Company appeared first on Boulder Media Design.
Levin Papantonio ∙ 6 weeks ago
Turning to Ashes In Their Mouths? http://www.levinlaw.com/news/turning-ashes-their-mouths For a long time, the four manufacturers of hip and joint replacements that controlled 75% of the market were laughing all the way to the bank. These four companies – Stryker, Biomet, Du Puy and Zimmer – have been beneficiaries of a dysfunctional health care “system” that has no financial interest in healing patients.
Levin Papantonio ∙ 6 weeks 2 days ago
Granuflo and Naturalyte - Lest We Forget http://www.levinlaw.com/news/granuflo-and-naturalyte-lest-we-forget “The evil men do lives after them...the good is oft interred with their bones.” -William Shakespeare in Julius Caesar, Act 3 Scene II This is an unfortunate fact of life for most of us natural humans. We may do great and wonderful things for others that are soon forgotten – but society hangs our mistakes around our necks like mill stones for the rest of our lives. This raises a question: how come this doesn't hold true for “corporate” people? Why are their mistakes and crimes so quickly forgotten? Let us try to rectify this situation...
Levin Papantonio ∙ 7 weeks ago
Hip Implant Manufactures and Kickbacks – What Doctors Had to Say http://www.levinlaw.com/news/hip-implant-manufactures-and-kickbacks-what-doctors-had-say In a recent news article, Gregory Demske, assistant inspector general for the U.S. Department of Health and Human Services, reported that the four largest manufacturers of hip replacements – all of which are facing legal action – paid “physician consultants” $800 million between 2002 and 2006. As defects in these designs became apparent and evidence surfaced to indicate that these companies were aware of the problems, these companies came under increasing scrutiny by the U.S. Department of Justice (DoJ).
Levin Papantonio ∙ 9 weeks 1 day ago
Pradaxa - Don't Panic http://www.levinlaw.com/news/pradaxa-dont-panic These words, the first bit of advice given to space travelers in the late Douglas Adams' Hitchhiker's Guide to the Galaxy, were also issued to the medical community recently regarding the anti-coagulant medication Pradaxa (dabigatran).
Levin Papantonio ∙ 10 weeks ago
Takeda Responds http://www.levinlaw.com/news/takeda-responds Jack Cooper, a retired communications worker, states that at age sixty-four – prior to being prescribed the diabetic drug Actos – he was in good health and looking forward to many more years with his wife of nearly fifty years and his grandchildren.
Levin Papantonio ∙ 11 weeks 1 day ago
Another Plaintiff’s Verdict in Bisphosphonate Jaw Case http://www.levinlaw.com/news/another-plaintiffs-verdict-bisphosphonate-jaw-case Last week, a jury in the United States District Court for the Middle District of Florida found that the manufacturer of the intravenous bisphosphonate Zometa failed to adequately warn of the risk of osteonecrosis of the jaw (“ONJ”) resulting from use of the drug. The jury also concluded that Zometa caused J. Hunter Chiles, a Florida resident, to suffer ONJ. Further, the jury determined that the drug manufacturer knowingly withheld information from the FDA about Zometa’s ability to cause ONJ. In finding for the Plaintiff, the jury awarded $250,000 in compensatory damages. The verdict is all the more satisfying given the case was hand-picked for trial by the drug manufacturer Novartis.
Recent Visitors
Levin Papantonio ∙ 2 days ago
Tylenol - Acetaminophen Liver Damage http://www.levinlaw.com/practice-areas/tylenol-acetaminophen-liver-damage Acetominophen is included as an ingredient in many medications. It ican be purchased over-the-counter, but is also added to some prescription drugs such as Vicodin and Percocet. Acetominophen is easy to get, but it is toxic to the liver and has a high risk of overdose. Acetominophen reactions is a common form of poisoning around the world. In the United States, the United Kingdom, Australia, and New Zealand, acetominophen is the most common cause of drug poisoning. It is the most common cause of liver poisoining and acute liver failure in the U.S.